Assessment of the different therapy options in the clinical management of Burning Mouth Syndrome (BMS)

Resumen

Introduction: The Burning Mouth Syndrome (BMS), whose definition and pathophysiology continue to be a topic of current debate, which also it does not have a universally accepted guidelines for its therapy. Therefore, the objective of this work is to present an assessment of the different treatments for the clinical management of patients with BMS based on the available scientific evidence, so that its application is evaluated in each specific case. Material and methods: PubMed (MEDLINE) and The Cochrane Library (Wiley) databases were searched for different treatments of BMS. With the data obtained regarding the effectiveness of each therapeutic modality and the adverse effects it produces, three different therapy lines have been developed. Results: In the first line of therapy we find chewing gum, LLLT (Low-level laser therapy), lingual protector, psychotherapy, topical clonazepam, ALA (Alpha Lipoic Acid) and Catauma. Conclusion: More research is needed to provide sufficient guidance to clinicians on effective therapeutic modalities and that allow to establish a correct strategy in the BMS management.